Vivo Opportunity, LLC's Net Worth

$573 Million

Estimate Recalculated Feb 16, 2024 06:26PM EST

Who is Vivo Opportunity, LLC?

Vivo Opportunity, LLC has an estimated net worth of $573 Million. This is based on reported shares across multiple companies, which include Sierra Oncology, Inc., Crinetics Pharmaceuticals, Inc., SOLENO THERAPEUTICS INC, Terns Pharmaceuticals, Inc., IO Biotech, Inc., ALX ONCOLOGY HOLDINGS INC, Kadmon Holdings, Inc., and Bolt Biotherapeutics, Inc..

SEC CIK

Vivo Opportunity, LLC's CIK is 0001728970

Past Insider Trading and Trends

2021 was Vivo Opportunity, LLC's most active year for acquiring shares with 19 total transactions. Vivo Opportunity, LLC's most active month to acquire stocks was the month of January. 2020 was Vivo Opportunity, LLC's most active year for disposing of shares, totalling 25 transactions. Vivo Opportunity, LLC's most active month to dispose stocks was the month of January. 2022 saw Vivo Opportunity, LLC paying a total of $47,954,257.80 for 6,895,296 shares, this is the most they've acquired in one year. In 2022 Vivo Opportunity, LLC cashed out on 7,041,258 shares for a total of $207,620,683.60, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sierra Oncology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.33M
$55.00
-$183,123,160.00
0
Jul 1
Form 4
+41.33%
800K
$27.00
$21,600,000.00
2.74M
Jan 31
Form 4
+31.95%
612.44K
$13.20
$8,084,168.40
2.53M
Jan 26
Form 4
+3,045.01%
1.86M
1.92M
Jan 29
Form 3
0
0
No matching records found

Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $37.74

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.02%
-528.00
$19.50
-$10,296.00
3.27M
Mar 9
Form 4
-0.21%
-13.46K
$21.70
-$291,587.00
6.54M
Feb 7 - Feb 10
Form 4
-0.41%
-13.46K
$22.80
-$306,888.00
3.28M
Feb 4
Form 4
-0.27%
-26.92K
$22.00
-$594,164.00
9.9M
Jan 29 - Jan 31
Form 4
-11.16%
-417.00K
$22.25
-$9,278,250.00
3.32M
Mar 20
Form 4
+59.34%
3.74M
$17.65
$6,575,421.40
10.04M
Jul 20
No matching records found

ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $14.995

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
4.22M
$19.00
$3,524,994.00
4.22M
Jul 21
No matching records found

Kadmon Holdings, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

Bolt Biotherapeutics, Inc. (BOLT) Snapshot price: $1.02

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.15%
-3.40K
$0.90
-$3,060.00
2.33M
Nov 21
Form 4
-1.35%
-86.05K
$0.93
-$79,933.22
6.31M
Nov 16 - Nov 20
Form 4
+8,933.46%
3.83M
$16.57
$2,995,480.00
3.87M
Feb 9
No matching records found